Minimally Invasive Surgery Market Growth Outlook

The Global Minimally Invasive Surgery (MIS) Market, valued at USD 63.18 billion in 2023, is projected to reach USD 139.39 billion by 2032, growing at a CAGR of 9.19% (2024–2032). This rapid expansion is driven by rising cases of cancer and cardiovascular diseases, patient preference for less invasive procedures, and groundbreaking innovations in robotic-assisted surgery and imaging technologies.

Quick Insights

• Market Size (2023): USD 63.18 Billion
• Forecast (2032): USD 139.39 Billion
• CAGR (2024–2032): 9.19%
• Top Region: North America
• Leading Device Segment: Surgical Devices (expected to reach USD 47 Billion)
• Top Surgery Type: Orthopedic procedures
• Key Players: Intuitive Surgical, Medtronic, Siemens Healthineers, Stryker, Teleflex, NuVasive

Revenue Breakdown (2023–2032)

• Global Market: USD 63.18 Billion (2023) → USD 139.39 Billion (2032)
• Surgical Devices Segment: USD 47 Billion by 2032
• Orthopedic Surgeries: Highest share due to aging population and rising orthopedic disorders

Where Are the Opportunities Emerging?

Can robotic-assisted surgery and AI-driven imaging redefine surgical outcomes? The answer lies in the growing adoption of robotic systems like da Vinci 5 and AI-powered visualization tools, which are enabling faster recovery, reduced blood loss, and improved surgical precision. Asia-Pacific is emerging as the fastest-growing region, supported by healthcare investments and demographic shifts.

Expert Comment

"Minimally invasive surgery is no longer a niche—it is becoming the global standard. With robotics, AI, and biosensors entering operating rooms, the next decade will be defined by precision, efficiency, and accessibility. Companies that balance innovation with cost efficiency will lead the transformation," said Dr. Rohan Kapoor, Principal Consultant at Introspective Market Research.

Regional & Segmentation Highlights

• North America: Leads the market with advanced healthcare infrastructure and adoption of robotic-assisted systems.
• Europe: Strong focus on laparoscopic and endoscopic procedures, supported by favorable regulations.
• Asia-Pacific: Fastest growth, driven by aging populations in China, India, and Japan.
• Latin America & Middle East: Emerging markets with growing demand but infrastructure challenges.
• Device Segmentation: Surgical devices dominate, while monitoring and visualization devices gain traction with AR and 3D imaging.
• Surgery Methods: Traditional laparoscopic methods remain cost-efficient, while robotic-assisted surgeries are expanding rapidly.
• End-Users: Hospitals remain the largest segment, with ambulatory surgery centers growing steadily.

Latest Breakthroughs

• Medtronic (2024): FDA approval of Evolut™ FX+ TAVR system for severe aortic stenosis.
• Siemens Healthineers (2024): Launch of Ciartic Move3 automated C-arm system, reducing imaging times by 50%.
• Intuitive Surgical (2024): FDA clearance of da Vinci 5 robotic system with 150+ technological advancements, including Force Feedback technology.

Cost Pressures & Efficiency

High costs of robotic systems remain a restraint. However, traditional laparoscopic methods and biosensor-driven monitoring offer cost-efficient alternatives. The rise of generics in surgical devices and government-backed investments are expected to reduce overall treatment costs while improving accessibility.

Benefits of Market Expansion

• Faster recovery and reduced hospital stays
• Lower risk of infection and blood loss
• Enhanced patient satisfaction and reduced need for pain medication
• Improved surgical precision through robotics and AI

About Introspective Market Research

Introspective Market Research (IMR) is a trusted global market research firm delivering actionable insights across industries. With expertise in healthcare, pharmaceuticals, and emerging technologies, IMR empowers businesses to make data-driven decisions.